TNFRSF17 and neoplasm: Mechanisms underlying resistance include BCMA target loss resulting from deletions or mutational events.7, 11 Antigen escape is also a frequent cause of acquired resistance to GPRC5D-targeted immunotherapies.12 29 30 Altogether this underscores the need for T-cell immunotherapies that target alternative tumor-associated antigens.